Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study

Drug and Alcohol Dependence, Journal Year: 2023, Volume and Issue: 248, P. 109940 - 109940

Published: May 22, 2023

Language: Английский

---

Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022

Obstetrics and Gynecology, Journal Year: 2024, Volume and Issue: 144(4), P. e101 - e104

Published: Aug. 30, 2024

This population-based cross-sectional study analyzed electronic health record data of pregnant individuals in an integrated care delivery system California to examine changes prenatal cannabis use through self-report and urine toxicology testing during standard between 2012 (n=33,546) 2022 (n=43,415), test whether trends differed by race ethnicity or age. The prevalence increased from 5.5% (95% CI, 5.3–5.8%) 9.0% 8.7–9.2%) (adjusted ratio [aPR] 1.82, 95% 1.72–1.92), with similar increases (aPR 1.70, 1.60–1.81) 2.12, 1.95–2.30). increase varied significantly across racial ethnic age groups, the highest among Black those aged 13–24 years. Although rates more slowly groups use, disparities persisted over time.

Language: Английский

---

Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes

Journal of Addiction Medicine, Journal Year: 2022, Volume and Issue: 17(3), P. e192 - e198

Published: Dec. 13, 2022

With legislative changes to cannabis legalization and increasing prevalence of use, is the most commonly used federally illicit drug in pregnancy. Our study aims assess perinatal outcomes associated with prenatal use disorder.We conducted a retrospective cohort using California linked hospital discharge-vital statistics data included singleton, nonanomalous births occurring between 23 42 weeks gestational age. χ2 Test multivariable logistic regression were for statistical analyses.A total 2,380,446 patients included, 9144 (0.38%) identified as during There was significantly increased risk adverse birthing person outcomes, including hypertension (adjusted odds ratio [AOR], 1.19; 95% confidence interval [CI], 1.06-1.34; P = 0.004), preeclampsia (AOR, 1.16; CI, 1.0-1.28; 0.006), preterm delivery 1.45; 1.35-1.55; < 0.001), severe maternal morbidity 1.22; 1.02-1.47; 0.033). Prenatal disorder also an neonatal respiratory distress syndrome 1.07-1.27; small age 1.47; 1.38-1.56; intensive care unit admission 1.24; 1.16-1.33; infant death 1.86; 1.44-2.41; 0.001). no statistically significant difference stillbirth 0.96; 0.69-1.34; 0.80) hypoglycemia 1.00-1.49; 0.045).Our suggests that mortality. As pregnancy becoming more prevalent, our findings can help guide preconception counseling.

Language: Английский

---

Pregnancy with multiple high-risk factors: a systematic review and meta-analysis

Journal of Global Health, Journal Year: 2025, Volume and Issue: 15

Published: Feb. 6, 2025

Abstract Background A wide spectrum of high-risk factors in pregnancy can lead to adverse outcomes or short- long-term health effects. Despite this, there has been no synthesis findings on the measurement, potential causes, and multiple (MHFP). We aimed address this gap by summarising existing research topic. Methods retrieved studies published up 3 June 2024 through systematic database searches used a narrative approach summarise patterns, MHFP. also estimated pooled MHFP prevalence meta-analysis with random effects model performed subgroup analyses meta-regression examine sources between-study heterogeneity. Results included 83 observational between 2010 2024, which 72% were from high-income countries. These studied be grouped into four categories: physical conditions, mental sociobehavioural problems, history. identified 16 among co-existing conditions most common pattern. The overall was 12% (95% confidence interval (CI) = 12–13), an increasing trend relatively higher levels low- middle-income countries (LMICs). observed heterogeneity measurement across studies, possibly due number risk definition About 78% investigated MHFP-associated for women offspring, only two examining maternal offspring later life. Conclusions Research emerging over past decade, but is far complete. burden worldwide, particularly LMICs. Maternal healthcare systems must shift multidisciplinary integrated framework so as better design implement prevention intervention programmes sustain healthy development next generation. Registration PROSPERO: CRD42022358889.

Language: Английский

---

Maternal Cannabis Use Disorder and Offspring Behavioral Outcomes: Findings from a Linked Data Cohort Study

Psychiatry Research, Journal Year: 2025, Volume and Issue: 346, P. 116404 - 116404

Published: Feb. 13, 2025

Language: Английский

---

Cannabis use disorder among insured pregnant women in the U.S., 2015-2020.

American Journal of Preventive Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

---

High Stakes: Exploring the Impact of Cannabis Use in Pregnancy and Lactation

NeoReviews, Journal Year: 2025, Volume and Issue: 26(4), P. e247 - e263

Published: April 1, 2025

Cannabis is the most commonly used federally illicit substance during pregnancy in United States, with an estimated prevalence of 3% to 30%. The American College Obstetricians and Gynecologists Academy Pediatrics discourage cannabis use breastfeeding due safety concerns for fetus infant. Despite these recommendations, nearly half active users continue pregnancy. In this review, we summarize pharmacology metabolism a focus on delta-9-tetrahydrocannabinol, psychoactive component plant, highlighting its significance quantifying exposure impact outcomes studies. We also provide concise review current evidence effects perinatal pregnancy, infant, childhood outcomes, acknowledging limitations evidence. Additionally, targeted counseling recommendations harm reduction strategies lactation considerations birthing parents who cannabis.

Language: Английский

---

Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years

Published: April 25, 2024

Public perception contrasts scientific findings on the depression-related effects of cannabis. However, earlier studies were performed when cannabis was predominantly illegal, its production mostly uncontrolled, and idea medical incipient only. We hypothesized that recent changes in attitudes legislations may have favorably affected research. In addition, publication bias against also decreased. To investigate this hypothesis, we conducted a systematic review research published over last three years. found 156 relevant studies. most cross-sectional studies, depression higher those who consumed than did not. An increase consumption typically followed by an depression, whereas withdrawal from ameliorated cases. Albeit reduced none these placebo controlled. clinical same period, average effect size larger investigated plausibility antidepressant reviewing molecular pharmacological Taken together, reviewed do not support herbal

Language: Английский

---

Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California

Addiction, Journal Year: 2024, Volume and Issue: 119(11), P. 1987 - 1997

Published: July 31, 2024

To estimate the strength of association between psychiatric disorders and substance use (SUD), cannabis disorder (CUD) during early pregnancy.

Language: Английский

---

Prenatal cannabis exposure in the clinic and laboratory: what do we know and where do we need to go?

Drug and Alcohol Dependence Reports, Journal Year: 2024, Volume and Issue: 13, P. 100282 - 100282

Published: Sept. 18, 2024

Language: Английский

---